ARMATA PHARMACEUTICALS, INC. (ARMP) Capital expenditures 2016–2025
ARMATA PHARMACEUTICALS, INC. (ARMP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$542,000FY2025 · since FY2016: $279,000 → $542,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $542,000 | -71.2% |
| FY2024 | $1.9M | -76.9% |
| FY2023 | $8.1M | +268.3% |
| FY2022 | $2.2M | +69.6% |
| FY2021 | $1.3M | +58.3% |
| FY2020 | $824,000 | +267.9% |
| FY2019 | $224,000 | -74.4% |
| FY2018 | $875,000 | +1408.6% |
| FY2017 | $58,000 | -79.2% |
| FY2016 | $279,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice